drugset / Trial / NCT06535945

Influence of Human Albumin Supplementation on Kidney Dysfunction After Liver Transplantation

NCT06535945

RandomizedParallel-groupOpen-labelTreatment

Summary

To verify whether albumin administration to achieve serum concentration above 30g/L (treated group) and its maintenance within plasmatic physiologic range (above 30 g/L) for five days diminishes rate of AKI at Day 7 after liver transplantation as compared to restrained albumin administration (when serum concentration is at 20 g/L or below (control)).

Timeline

Start
2025-03-26
Primary completion
2028-04-26
Completion
2028-04-26

Drugs

EvaluationDrugModalityDoseRoute
Subject Albumin Protein / enzyme biologic

Indications